The quest for a treatment that can combat Alzheimers remains frustrating and expensive but Andrew Lo believes he may have a path forward A finance professor who directs the Laboratory for Financial Engineering at the MIT Sloan School of Management Lo thinks that a publicprivate partnership could solve some of the funding issues that have plagued drug discovery and development The hopeÂ is to create what the pharmaceutical world likes to call lots of shots on goals We spoke with Lo about his idea We need a change in our approach he says Right now the risk of failure in developing an Alzheimers treatment is far too high for any single pharmaceutical company to take on And if we dont do anything about it its going to be a very long time before we develop an effective therapy